Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy

Sponsor
University of Sao Paulo (Other)
Overall Status
Completed
CT.gov ID
NCT01518023
Collaborator
(none)
240
1
11
21.9

Study Details

Study Description

Brief Summary

There is evidence that gastrointestinal operations for non weight-losing purposes are beneficial for diabetes mellitus. Aiming to analyze such hypothesis, patients submitted to gastric bypass for morbid obesity, gastrectomy for gastric cancer and colectomy for colo-rectal cancer will be compared. The end point will be changes in fasting blood glucose and hemoglobin A1c concentration.

Condition or Disease Intervention/Treatment Phase
  • Other: Interview, questionnaire, updated biochemical tests

Detailed Description

In a prospective protocol with retrospective information, patients (N=240) undergoing bariatric Roux-en-Y gastric bypass (n=80), cancer subtotal or total gastrectomy (n=80) and right colectomy or rectosigmoidectomy (n=80) with follow-up >3 years free of disease, with or without previously impaired fasting blood glucose, will be recruited. Patients will be submitted to a questionnaire involving diet, diagnosis of diabetes and glucose-lowering drugs, body weight and other clinical items. Preoperative information available in the hospital system will be completed and current findings will be updated, including body mass index and biochemical measurements. Using the outcomes of the bariatric population as benchmark, both concerning diabetics that were ameliorated and nondiabetics that progressed to new-onset diabetes,results in the other groups will be compared. The study should answer whether gastric and colorectal surgery for cancer 1) Are beneficial for established diabetes; 2) Attenuate the conversion of normal patients to diabetes, both within a follow-up period of 3- 12 years;

Study Design

Study Type:
Observational
Actual Enrollment :
240 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy
Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Dec 1, 2011
Actual Study Completion Date :
Dec 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Cancer gastrectomy

Patients previously submitted to partial/total gastrectomy for gastric cancer

Other: Interview, questionnaire, updated biochemical tests
Patients will be interviewed and questioned about nutritional status, diet, drugs and diagnosis/clinical course of diabetes. Routine biochemical tests will be searched and if necessary updated.

Colorectal cancer operation

Patients previously submitted to right colectomy or rectosignoidectomy for cancer

Other: Interview, questionnaire, updated biochemical tests
Patients will be interviewed and questioned about nutritional status, diet, drugs and diagnosis/clinical course of diabetes. Routine biochemical tests will be searched and if necessary updated.

Bariatric patients

Morbidly obese participants who underwent antiobesity Roux-en-Y gastric bypass

Other: Interview, questionnaire, updated biochemical tests
Patients will be interviewed and questioned about nutritional status, diet, drugs and diagnosis/clinical course of diabetes. Routine biochemical tests will be searched and if necessary updated.

Outcome Measures

Primary Outcome Measures

  1. Fasting blood glucose [3-12 years change]

    Glucose improvement or deterioration comparing preoperative versus late postoperative value. Classification according to the American Diabetes Association

Secondary Outcome Measures

  1. HbA1c [3-12 years]

    Same as fasting blood glucose (preoperative versus current change). Classification according to the American Diabetes Association.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Follow-up period > 3 years,

  • weight stable in the last year

Exclusion Criteria:
  • Reoperation or take-down of original operation,

  • consumptive diseases,

  • protein-calorie malnutrition,

  • organ failures,

  • pancreatic surgery,

  • cell or organ transplantation,

  • type 1 diabetes,

  • cognitive impairment or Alzheimer disease,

  • refusal to participate in the protocol

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital das Clinicas- Central Institute ICHC- 9th Floor Rm 9077 Sao Paulo Brazil 05403-900

Sponsors and Collaborators

  • University of Sao Paulo

Investigators

  • Study Chair: Joel Faintuch, MD, PhD, Hospital das Clinicas, Sao Paulo, Brazil

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Joel Faintuch, Associate Professor, Department of Gastroenterology, University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT01518023
Other Study ID Numbers:
  • Lessdiabetes
First Posted:
Jan 25, 2012
Last Update Posted:
Jan 25, 2012
Last Verified:
Jan 1, 2012
Keywords provided by Joel Faintuch, Associate Professor, Department of Gastroenterology, University of Sao Paulo
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 25, 2012